Fulgent Genetics (FLGT) Consolidated Net Income (2016 - 2026)
Fulgent Genetics' Consolidated Net Income history spans 11 years, with the latest figure at -$25.3 million for Q1 2026.
- On a quarterly basis, Consolidated Net Income fell 112.01% to -$25.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$14.3 million, a 61.01% increase, with the full-year FY2025 number at -$1.0 million, up 97.4% from a year prior.
- Consolidated Net Income hit -$25.3 million in Q1 2026 for Fulgent Genetics, down from $37.0 million in the prior quarter.
- Over the last five years, Consolidated Net Income for FLGT hit a ceiling of $153.6 million in Q1 2022 and a floor of -$25.3 million in Q1 2026.
- Historically, Consolidated Net Income has averaged $3.6 million across 5 years, with a median of -$11.6 million in 2023.
- Biggest five-year swings in Consolidated Net Income: plummeted 1100.74% in 2023 and later surged 3631.52% in 2025.
- Tracing FLGT's Consolidated Net Income over 5 years: stood at -$24.1 million in 2022, then skyrocketed by 202.09% to $24.6 million in 2023, then plummeted by 104.26% to -$1.0 million in 2024, then surged by 3631.52% to $37.0 million in 2025, then tumbled by 168.37% to -$25.3 million in 2026.
- Business Quant data shows Consolidated Net Income for FLGT at -$25.3 million in Q1 2026, $37.0 million in Q4 2025, and -$6.8 million in Q3 2025.